Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22833975 | 1.00 | ERN1 (0.32) | ERN1RAPGEF4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2462924 | 0.83 | NPSR1 (0.39) | KDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL14992136 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL2463070 | 0.83 | CES1 (0.32) | ERN1 | |
| SCHEMBL14992458 | 0.83 | CYP3A4 (0.38) | ERN1MEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL21495062 | 0.81 | POLB (0.39) | ALDH1A1 | |
| SCHEMBL2467572 | 0.79 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL2461408 | 0.79 | ALDH1A1 (0.37) | ERN1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL14993162 | 0.79 | MAPT (0.33) | MAPT | |
| SCHEMBL2464227 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3023477-B1 | COMPOSITION, AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL CO (JP) | 2019-02-06 | — | — | EP | disclosed |
| US-9929359-B2 | Composition and light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-27 | — | — | US | disclosed |
| US-20160164008-A1 | COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160164008-A1 | COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-09 | — | — | US | disclosed |
| EP-3023477-A1 | COMPOSITION, AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company Limited (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-20150162551-A1 | LIGHT-EMITTING COMPOUND | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-06-11 | — | — | US | disclosed |
| US-20150162551-A1 | LIGHT-EMITTING COMPOUND | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-06-11 | — | — | US | disclosed |
| EP-2257528-A2 | 1 IBETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS | Sterix Limited (GB) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009106817-A2 | COMPOUND | STERIX LIMITED (GB) | 2009-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150162551-A1 | LIGHT-EMITTING COMPOUND | AP3D1, GRIN1, KISS1R | ERN1 1099/4885RAPGEF4 2175/4885SLC6A2 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.